focus -WSS

focus

author：explore 2025-09-27 19:27:58 - browse：347

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Congress extends some pandemic preparedness programs

WSS

Eli Lilly expects to double planned employment in Boston center

What will Novo Nordisk's VC do with its influx of cash?

Senate committee scrutinizes Medicare Advantage brokers

HHS leader on health, climate change and biopharma emissions

Eli Lilly expects to double planned employment in Boston center

Some top drug companies are starting to take action on climate

hotspot

focus

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

RSV injection headlines need to be accurate for good uptake

Peter Hotez and the public health issue of online harassment

FDA struggles to regulate food additives, sometimes for decades

Trump demands the U.S. pay no more for drugs than other countries … again

Solve the antibiotic resistance crisis with preventive drugs

Cancer drug shortages should be causing more outrage

Lawsuit highlights wrinkle for disputes over surprise medical bills

BioMarin wins approval for gene therapy to treat hemophilia A

Experts study whether long Covid risk adds up with each reinfection

explore

WHO recommends second malaria vaccine

Congress extends some pandemic preparedness programs

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Will Ozempic

STAT Summit: Michael J. Fox on progress in Parkinson's research

Setback for rare diseases as Taysha Gene Therapies pulls back

focus

hotspot

knowledge

hotspot